J. B. Chemicals & Pharmaceuticals announced the cessation of Mr. Jason D’souza as the Executive Vice President. His departure was effective from the closing of business hours on March 6, 2026. The company acknowledged a delay in officially intimating this change to the stock exchanges, which was rectified via a subsequent communication. Mr. D’souza’s resignation letter, received on February 6, 2026, indicated a three-month notice period.
Cessation of Key Personnel
J. B. Chemicals & Pharmaceuticals Limited issued a formal disclosure concerning a change in its Senior Management Personnel. The company confirmed that Mr. Jason D’souza has ceased to be the Executive Vice President, effective March 6, 2026, following the close of business on that date.
Disclosure and Rectification
The disclosure was made in response to a request from the BSE Limited following an earlier intimation dated March 10, 2026. The organization noted that there was an inadvertent delay in submitting the complete cessation information to the stock exchanges previously.
Details of Cessation
The specific details required for disclosure regarding the change are summarized below:
- Reason for change: Resignation
- Date of cessation: With effect from closing of business hours on March 6, 2026.
Resignation Context
An enclosed copy of Mr. D’souza’s resignation letter, dated February 6, 2026, indicated his intent to formally resign and expressed his commitment to serving a 3-month notice period to ensure a smooth transition of responsibilities.
Source: BSE
